The World Health Organization (WHO) has criticized a US-funded newborn vaccine trial, calling it “unethical”. The trial in question involves the birth dose of the hepatitis B vaccine, with the Centers for Disease Control and Prevention (CDC) awarding $1.6 million for the study to be conducted in Guinea-Bissau.
The study, which is being funded by the CDC, has raised concerns regarding its ethical implications. The CDC has provided a significant amount of funding, with $1.6 million being allocated for the study. The location of the study, Guinea-Bissau, may also pose additional challenges and considerations for the trial.
The WHO’s criticism of the trial as “unethical” may have significant implications for the study’s future. The WHO’s stance on the matter may lead to increased scrutiny and potentially impact the trial’s continuation. Further information on the trial and the WHO’s concerns is expected to be released in the coming days, which may shed more light on the situation and what happens next.
Leave a Reply